Skip to main content

About your Search

20130104
20130112
Search Results 0 to 8 of about 9 (some duplicates have been removed)
're accelerating in 2013. the first, when you speak of big themes, you cannot ignore the revolution in energy in this country. >> buy, buy, buy! >> we have so much of it, particularly so much natural gas, it will not be just 2013, 2012, but a multi-year game changer. while we're thrilled about the possible north american energy independence, and by the way, the american technology behind them, don't forget that, we need to ask, how can this theme make us money? i mean, this is "mad money," not mad energy sufficiency. who are the principal winners from years of ultra cheap natural gas to come? the answer, the chemical companies. the plastic makers. because they're the big beneficiaries of the remarkably low cost of natural gas related feed stock, what goes into plastic. and the best of the best, dow chemical, ppg, westlake, eastman, georgia gulf and liondel basin. they thrive on the cost advantage of two of my absolute favorite gals when it comes to making plastic, poly and ethel. at this moment, only dow chemicals has done much to capitalize on the cheap domestic energy. the company is spendi
, export economy? the u.s. has become one of the world's largest energy producers, but while natural gas production has increased, it's been largely ignored as a domestic fuel. but could exporting it help fill up your tank? cramer talks with cheniere energy's ceo next. and later, smooth operator? spam maker hormel foods put another consumer brand on its plate today after it forked over $74 million to buy skippy peanut butter. could this layer another level of success to this story or will investors have an allergy? don't miss the ceo, all coming up on "mad money." >> don't miss a second of "mad money." follow @jimcramer on twitter. have a question? tweet cramer, #madtweets. send jim an e-mail or give us a call at 1-800-743-cnbc. miss something? head to madmoney.cnbc.com. >>> it's one of the great economic tragedies of our time. we have all this incredibly cheap, clean and abundant natural gas in this country yet it seems like nobody here wants to use the stuff. as long as it sells for less than 4 bucks per thousand cubic feet, nobody wants to drill for it. it's currently selling for $3 a
to recognize the inherent value of paypal. and you buy the same thing if it happens again. kinder morgan energy partners, kmw. the mass limited partnership finished 2012 terribly. in part because people worried the tax breaks would be erased by the burgeoning fiscal cliff. buyers remain under a cloud. declining oil prices and the debt ceiling negotiations and new revenue raised by taxing them. you know what? that's the same old, same old. i don't care. like kinder morgan. looking for an entry point. yield above 6%, and currently 5.77%. you know what? if it happens, before they report, i would pounce. bank of america reports on thursday morning. okay. could this be the breakout quarter for bac, b-a-c-. the funny thing about the market. when everyone expects something good, you tend not to go it. the stock super bowl momentarily. this is a long-term positive story that needs to be button weakness, it bothers me that the stock caught two -- not one, but two downgrades in the past week. as you will hear later, short term, some concern. that's just short term, though. citigroup, the first conference
master while recording my debut album. how you ask? with 5-hour energy. i get hours of energy now -- no crash later. wait to see the next five hours. >>> the relief, finally had positive action today, but we all know with the battles over the debt ceiling, we could be looking at some very difficult moments over the next couple of months. and that's why all week we've been focusing on the noneconomic big jpmorgan health care conference that started on monday, where biotech and pharma countries strut their stuff. acor, this is a small billion dollar biopharma firm focused on neurology. back in 2010, accorda received approval for a drug called empira that helps people with multiple sclerosis gain their ability to walk. talk about how horrible this disease is, but it is also a lucrative disease for those who are trying to combat it, why? because it's a lifelong chronic condition. at this point, though, acorda has gotten all the low-hanging fruit. the really impressive thing about this story is they could have multiple indications. that's the holy grail of the drug business. right now
stock is energy transfer partners. >> listen to me and listen good. if they do an equity offering the ceo will be on the wall of shame. do you hear me? wall of shame if you do an equity offering. my charitable trust ounce it. it's the worst stock that the trust owns. and that, ladies and gentlemen, is the conclusion of the lightning round. [ buzzer ] >> announcer: the lightning round is sponsored by td ameritrade. >> happy new year dr. cramer. >> glad i got that doctorate, man. what's going on? >> breaking bad boo-yah from the land of enchantment. >> a walter white jesse boo-yah back at you. >> happy boo-yah new year to you and your "mad money" staff, jim. >> i had the best staff in the world. let me say i did beat them all in fantasy football. i was going to work it in. this was the best moment. that's a different show. shout out. >> welcome to this week's edition of "cooking with cramer." >> i love peanut butter. >> join us next time for more cooking with cramer. >> sometimes the best stock picks are ripped from the headlines. just like an episode of "law & order" we're on track
Search Results 0 to 8 of about 9 (some duplicates have been removed)